In contrast to Th1 cells, Th2 cells express CCR3, CCR4, and CCR8 receptors on their surface and can promote tumor progression by exerting immunomodulatory functions in response to stimulation by the corresponding ligands. This evidence concerns the gene CCR4 and neoplasm.